GRCE
Grace TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
GRCE Profile
Grace Therapeutics, Inc.
A late-stage biopharma company with drug candidates addressing rare and orphan diseases
103 Carnegie Center Suite 300, Princeton, New Jersey 08540
--
Grace Therapeutics, Inc., was established on February 1, 2002. They focus on developing and commercializing products for rare and orphan diseases that have the potential to improve clinical outcomes through the use of their novel drug delivery technologies. They seek to apply new proprietary formulations to approved and marketed pharmaceutical compounds to achieve enhanced efficacy, faster onset of action, reduced side effects, easier drug delivery and improved patient compliance.
